Finance

Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?

Prediction: Oracle Stock Trails the S&P 500 Through 2030

Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks

Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line